Synonym
Etofamide; Ethylchlordiphene; Eticlordifene; Etofamida;
IUPAC/Chemical Name
2,2-Dichloro-N-(2-ethoxyethyl)-N-((p-nitrophenoxy)benzyl)-acetamide
InChi Key
UBVOWXNDEAGIBN-UHFFFAOYSA-N
InChi Code
InChI=1S/C19H20Cl2N2O5/c1-2-27-13-12-22(18(24)17(20)21)19(14-6-4-3-5-7-14)28-16-10-8-15(9-11-16)23(25)26/h3-11,17,19H,2,12-13H2,1H3
SMILES Code
O=C(N(CCOCC)C(OC1=CC=C([N+]([O-])=O)C=C1)C2=CC=CC=C2)C(Cl)Cl
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
Preparing Stock Solutions
The following data is based on the
product
molecular weight
427.28
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Olaeta Elizalde R, Pérez Huacuja R, Nájera Ruano S. [Comparison of quinfamide vs etofamide in the Mexican population with intestinal amebiasis]. Acta Gastroenterol Latinoam. 1996;26(5):277-80. Spanish. PubMed PMID: 9363264.
2: Cedillo-Rivera R, Muñoz O. In-vitro susceptibility of Giardia lamblia to albendazole, mebendazole and other chemotherapeutic agents. J Med Microbiol. 1992 Sep;37(3):221-4. PubMed PMID: 1518040.
3: Cedillo-Rivera R, Tapia-Contreras A, Torres J, Muñoz O. In vitro susceptibility of Entamoeba histolytica to fluoroquinolones, nitrofurans and other antiamebic agents. Arch Med Res. 1997;28 Spec No:295-7. PubMed PMID: 9033107.
4: Gatti S, Cevini C, Bernuzzi AM, Bruno A, Scaglia M. Symptomatic and asymptomatic amoebiasis in two heterosexual couples. Ann Trop Med Parasitol. 1999 Dec;93(8):829-34. PubMed PMID: 10715677.
5: Huggins D. [Clinical trial of etophamide in the treatment of chronic intestinal amebiasis]. G E N. 1980 Jan-Mar;34(1):51-4. Portuguese. PubMed PMID: 6778767.
6: Pamba HO, Estambale BB, Chunge CN, Donno L. Comparative study of aminosidine, etophamide and nimorazole, alone or in combination, in the treatment of intestinal amoebiasis in Kenya. Eur J Clin Pharmacol. 1990;39(4):353-7. PubMed PMID: 2076717.
7: Slighter RG, Yarinsky A, Drobeck HP, Bailey DM. Activity of quinfamide against natural infections of Entamoeba criceti in hamsters: a new potent agent for intestinal amoebiasis. Parasitology. 1980 Aug;81(1):157-68. PubMed PMID: 6252530.
8: Cozzi P, Rampinelli D, Tonani R, Meinardi G, Trane F. [Identification of metabolites of an antiamebic agent in rat serum]. Farmaco Prat. 1983 Sep;38(9):344-51. Italian. PubMed PMID: 6641922.
9: Cavier R, Cenac J. [Pharmacologic study of the amebicidal properties of ethychlordiphene (ethofamid)]. Bull Soc Pathol Exot Filiales. 1972 May-Jun;65(3):399-404. French. PubMed PMID: 4678937.
